TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AVBP

ArriVent BioPharma, Inc.

Healthcare · Biotechnology

28.40$ +2.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns ArriVent BioPharma, Inc. (AVBP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 65.1% of the shares are freely tradable; institutional investors hold 95.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 95.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 65.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 18.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 49Mio.

Largest Shareholders

Institutions

Institutions AVBP
Name Stake (%) Shares Change (%) Date
Suvretta Capital Management, LLC 8.93 4,401,083 +7.2 03/31/2026
Hillhouse Capital Advisors, Ltd. 7.97 3,929,117 +0.0 06/30/2026
Orbimed Advisors LLC 6.14 3,027,328 +0.0 03/31/2026
FMR Inc 6.12 3,016,132 -18.6 03/31/2026
BlackRock Inc 5.13 2,530,301 +6.6 03/31/2026
Octagon Capital Advisors LP 4.00 1,971,054 +0.0 06/30/2026
Novo A/S 3.94 1,942,142 +0.0 03/31/2026
Sofinnova Ventures 3.44 1,696,752 +0.0 03/31/2026
Vivo Capital, LLC 3.41 1,682,097 +89.9 06/30/2026

Funds

Funds AVBP
Name Stake (%) Shares Change (%) Date
HBM Healthcare Investments AG Ord 5.17 2,548,185 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?